TORONTO and RIONEGRO, Colombia, June 23,
2021 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the
"Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of
Colombia's premier cultivator and
producer of medicinal-grade cannabis extracts, PharmaCielo Colombia
Holdings S.A.S., today announced that Henning von Koss, Chief Executive Officer will
participate in a discussion at the Cantor Fitzgerald International
Cannabis Forum on June 28, 2021.
DETAILS
Date: Monday, June 28, 2021.
Time: 12:00pm ET
To
Register: https://us06web.zoom.us/webinar/register/WN_HMS7kf5zQEOpc1drtylmzA
To receive additional information or schedule a one-on-one
meeting with management, please contact your conference
representative or the Company's investor relations team at
investors@pharmacielo.com.
About PharmaCielo
PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company,
headquartered in Canada, with a
focus on ethical and sustainable processing and supplying of all
natural, medicinal-grade cannabis oil extracts and related products
to large channel distributors. PharmaCielo's principal (and wholly
owned) subsidiary is PharmaCielo Colombia Holdings S.A.S.,
headquartered at its cultivation and processing centre located in
Rionegro, Colombia.
The board of directors and executive team of PharmaCielo are
comprised of a diversely talented group of international business
executives and specialists with relevant and varied expertise.
PharmaCielo recognized the significant role that Colombia's ideal location and climate play in
building a sustainable business in the medical cannabis industry,
and the Company, together with its directors and executives, is
executing on a business plan focused on supplying the international
marketplace.
Forward-Looking Statements
This news release contains certain "forward-looking
information" and "forward-looking statements" (collectively
referred to as "forward-looking statements"). These forward-looking
statements relate to future events or the Company's future
performance. All statements other than statements of historical
fact are forward-looking statements. Particularly, information
regarding our expectations of future results, targets, performance
achievements, prospects or opportunities is forward-looking
information.
Forward-looking statements are based on management's
assumptions at the date the forward-looking statements are
provided, including assumptions regarding: the Company's ability to
execute its business plan, including the growth of its global sales
team, as currently contemplated; the Company's ability to obtain
necessary governmental, regulatory, and TSXV approvals for the
export of its products from Colombia and import of its products into other
countries; there being sufficient demand for the Company's
products; that the Company's development plans will not change as a
result of unforeseen events; that the Company's business generally
and shipping logistics are not disrupted by COVID 19 or other
factors; that the Company will be able to maintain its customer
contracts in good standing; that the Company will be able to obtain
GMP and EU-GMP certification for the Company's Processing and
Extraction Center ("PEC"); that potential customers will be
satisfied with the results of audit processes; that any changes to
Colombian cannabis legislation will not negatively impact the
Company's business; that the Company will be able to locate and
retain necessary personnel to achieve its business goals; the
Company's ability to maintain its distribution contracts in good
standing; and the accuracy of the Company's projections regarding
the market for cannabinoid products; currency exchange rates; and
competition in the Company's markets.
Though management believes that its assumptions are
reasonable in the circumstances, forward-looking statements involve
known and unknown risks, uncertainties and other factors that may
cause the Company's actual results, performance or achievements to
differ materially from all or any of the future results,
performance or achievements expressed or implied by forward-looking
statements. Factors that could cause the Company's actual results,
performance, or achievements to differ from the forward-looking
statements include, but may not be limited to the risk that: any of
the assumptions referred to above proves not to be valid
or reliable, and additional risks described in the Company's Annual
Information Form for the year ended December
31, 2019 filed with the Canadian securities regulatory
authorities under the Company's SEDAR profile
at www.sedar.com. Accordingly, readers should not place
undue reliance on forward-looking statements.
Except as required by law, PharmaCielo undertakes no
obligation to publicly update any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
SOURCE PharmaCielo Ltd.